Variable | Adjusted OR (95% CI) | P value |
---|---|---|
Sex | ||
Female | Reference | . |
Male | 0.63 (0.29–1.34) | 0.233 |
Second-line regimen group | ||
ATV/r | Reference | . |
LPV/r | 0.46 (0.20–1.03) | 0.060 |
Age at switch to second-line, per 5 year increase | 0.91 (0.76–1.10) | 0.332 |
CD4 count cell/μl, at switch to second-line | 0.99 (0.99–1.00) | 0.468 |
Time (months) on first-line therapy | 1.00 (0.99–1.02) | 0.701 |
Time (years) after switch to viral load date | 1.27 (0.95–1.68) | 0.103 |